CRGX: CARGO Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 207.02
Enterprise Value ($M) 145.25
Book Value ($M) 282.46
Book Value / Share 6.13
Price / Book 0.73
NCAV ($M) 245.31
NCAV / Share 5.33
Price / NCAV 0.84

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 6.30
Current Ratio 6.30

Balance Sheet (mrq) ($M)
Current Assets 324.81
Assets 361.96
Liabilities 79.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -187.37
Net Income -167.50

Cash Flow Statement (mra) ($M)
Cash From Operations -139.74
Cash from Investing -305.08
Cash from Financing 103.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-15 13G Cormorant Asset Management, LP 7.33
05-14 13G/A Janus Henderson Group Plc 0.00 -99.72
05-14 13G/A Price T Rowe Associates Inc /md/ 1.30 -77.82
05-12 13G/A Fmr Llc 11.30 -15.71
04-28 13G Madison Avenue Partners, LP 6.80
04-23 13G/A Perceptive Advisors Llc 2.50 -65.93
02-21 13D Tang Capital Management Llc 5.90
11-14 13G/A Samsara BioCapital, L.P. 9.60 7.13
11-14 13G/A Rtw Investments, Lp 9.99
11-08 13G BlackRock, Inc. 5.50 0.00
10-21 13G/A Red Tree GP, LLC 4.60 -15.02

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q PART I – FINANCIAL INFORMATION Item 1. Financial Statements. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations PART II—OTHER INFORMATION
2025-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-03 46,152 914,644 5.05
2025-06-02 15,573 691,181 2.25
2025-05-30 62,732 444,916 14.10
2025-05-29 25,223 1,008,241 2.50

(click for more detail)

Similar Companies
COLL – Collegium Pharmaceutical, Inc. CPIX – Cumberland Pharmaceuticals Inc.
CRBU – Caribou Biosciences, Inc. CRNX – Crinetics Pharmaceuticals, Inc.
CTMX – CytomX Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io